Drug Res (Stuttg) 2016; 66(03): 121-125
DOI: 10.1055/s-0035-1550042
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Cytotoxic Potential and Molecular Characterization of Fungal Endophytes from Selected High Value Medicinal Plants of the Kashmir Valley – India

Authors

  • R. A. Dar

    1   Biotechnology Division, CSIR – Indian Institute of Integrative Medicine, Sanatnagar – Srinagar, Kashmir, India
  • P. H. Qazi

    1   Biotechnology Division, CSIR – Indian Institute of Integrative Medicine, Sanatnagar – Srinagar, Kashmir, India
  • I. Saba

    1   Biotechnology Division, CSIR – Indian Institute of Integrative Medicine, Sanatnagar – Srinagar, Kashmir, India
  • S. A. Rather

    1   Biotechnology Division, CSIR – Indian Institute of Integrative Medicine, Sanatnagar – Srinagar, Kashmir, India
  • Z. A. Wani

    2   Cancer Pharmacology Division, CSIR – Indian Institute of Integrative Medicine, Jammu – Tawi, India
  • A. K. Qazi

    2   Cancer Pharmacology Division, CSIR – Indian Institute of Integrative Medicine, Jammu – Tawi, India
  • A. A. Shiekh

    1   Biotechnology Division, CSIR – Indian Institute of Integrative Medicine, Sanatnagar – Srinagar, Kashmir, India
  • A. Manzoor

    1   Biotechnology Division, CSIR – Indian Institute of Integrative Medicine, Sanatnagar – Srinagar, Kashmir, India
  • A. Hamid

    2   Cancer Pharmacology Division, CSIR – Indian Institute of Integrative Medicine, Jammu – Tawi, India
  • D. M. Modae

    2   Cancer Pharmacology Division, CSIR – Indian Institute of Integrative Medicine, Jammu – Tawi, India
Further Information

Publication History

received 28 December 2014

accepted 05 May 2015

Publication Date:
26 May 2015 (online)

Abstract

The present study explores the fungal endophytes from selected high value medicinal plants to check their activities at in-vitro and in-vivo level. The in-vitro cytotoxicity of selected endophytes revealed potent growth inhibition against human cancer cell lines of leukemia (THP-1), lung (A549), prostate (PC-3), colon (Caco-2), neuroblastoma (IMR-32) and breast (MCF-7) at a concentration of 100 µg/ml. Among them the endophytic strains i. e., IIIM2, IIIM3, IIIM7 and IIIM8 showed most significant growth inhibition against colon (Caco-2), prostate (PC-3), lung (A549) and leukemia (THP-1) cancer cell lines. At the in-vivo level maximum (58.95%) tumor growth inhibition was documented with the extract of IIIM2 against Ehrlich Ascites Carcinoma mouse modal. All the potent fungal endophytic strains were characterized using ITS 4 and ITS 5 region sequencing and phylogenetic analysis was ascertained among them. This paper confirms the 2 elite endophytic fungal strains, IIIM2 and IIIM8, have the potential to act as a source of new anticancer compounds.